Aytu Biopharma (AYTU) Prepaid Assets (2011 - 2026)
Aytu Biopharma's (AYTU) quarterly Prepaid Assets came in at $8.7 million in Q1 2026, up 16.17% year-on-year from $7.5 million in Q1 2025, and up 30.51% on a QoQ basis from $6.6 million in Q4 2025.
Aytu Biopharma (AYTU) Prepaid Assets (2011 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 15 years of Prepaid Assets data on file, last reported at $8.7 million in Q1 2026.
- On a quarterly basis, Prepaid Assets rose 16.17% year-over-year to $8.7 million in Q1 2026; TTM through Mar 2026 was $8.7 million, a 16.17% increase from a year earlier, with the FY2025 full-year figure at $5.6 million, up 10.61% from the prior year.
- Prepaid Assets for Q1 2026 stood at $8.7 million, up from $6.6 million in the prior quarter.
- Over the last five years, Prepaid Assets for AYTU reached as high as $12.0 million in Q4 2022 and fell as low as $888000.0 in Q1 2022.
- Historically, Prepaid Assets has averaged $6.3 million across 5 years, with a median of $6.6 million in 2025.
- Across the five-year window, Prepaid Assets jumped 1074.44% in 2023 and sank 90.38% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $12.0 million in 2022, then plunged by 88.88% to $1.3 million in 2023, then surged by 362.64% to $6.2 million in 2024, then gained by 7.62% to $6.6 million in 2025, then surged by 30.51% to $8.7 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $8.7 million in Q1 2026, $6.6 million in Q4 2025, and $5.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Aytu Biopharma | 1.43 Mn | -25.28 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.66 Mn |
| Dec 31, 2025 | 6.64 Mn |
| Sep 30, 2025 | 5.15 Mn |
| Jun 30, 2025 | 5.64 Mn |
| Mar 31, 2025 | 7.46 Mn |
| Dec 31, 2024 | 6.17 Mn |
| Sep 30, 2024 | 5.73 Mn |
| Jun 30, 2024 | 5.10 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Sep 30, 2023 | 7.04 Mn |
| Jun 30, 2023 | 7.16 Mn |
| Mar 31, 2023 | 10.43 Mn |
| Dec 31, 2022 | 11.99 Mn |
| Sep 30, 2022 | 9.02 Mn |
| Jun 30, 2022 | 7.38 Mn |
| Mar 31, 2022 | 888,000.00 |
| Dec 31, 2021 | 11.30 Mn |
| Sep 30, 2021 | 1.20 Mn |
| Jun 30, 2021 | 9.78 Mn |